361 Capital’s Medtronic MDT Stock Holding History

361 Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-831	Closed	-$64K	–	129
2015 Q4	$64K	Buy	+831	New	+$62.6K	0.52%	62

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

361 Capital's MDT Position: Q1 2016 in Review

361 Capital sold out of Medtronic (MDT) in Q1 2016, closing a stake of 831 shares — an estimated $64K sold.

361 Capital first reported a position in MDT in Q4 2015 and held it in 1 quarter. The position peaked at $64K in Q4 2015. 1,240 funds tracked by Wall St. Rank hold MDT as of Q1 2016.

361 Capital reported no remaining Medtronic position as of Q1 2016 after selling out during the quarter.
361 Capital sold 831 Medtronic shares in Q1 2016, an estimated $64K.
361 Capital first reported a position in Medtronic in Q4 2015 and held it in 1 quarter.
361 Capital's Medtronic position peaked at $64K in Q4 2015.
1,240 funds tracked by Wall St. Rank held Medtronic as of Q1 2016.

Based on 361 Capital's 13F filing for Q1 2016, filed 16 May 2016.